CONGENITAL ICHTHYOSIS
Clinical trials for CONGENITAL ICHTHYOSIS explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL ICHTHYOSIS trials appear
Sign up with your email to follow new studies for CONGENITAL ICHTHYOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New ointment shows promise for rare skin condition
Disease control CompletedThis Phase 3 study tested an ointment called TMB-001 in 153 people aged 6 and older with X-linked or ARCI ichthyosis, conditions that cause dry, scaly, and cracked skin. Participants applied the ointment or a placebo daily for 12 weeks, with some continuing for maintenance. The g…
Matched conditions: CONGENITAL ICHTHYOSIS
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New ointment shows promise for rare skin scaling disease
Symptom relief CompletedThis study tested two strengths of a topical isotretinoin ointment (TMB-001) in 34 people aged 9 and older with congenital ichthyosis, a rare genetic skin condition causing severe scaling. The main goal was to see if the ointment could reduce scaling by at least 50% compared to a…
Matched conditions: CONGENITAL ICHTHYOSIS
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Living with ichthyosis: what 20 patients reveal about daily struggles
Knowledge-focused CompletedThis study interviewed 20 adults aged 30 and older with congenital ichthyosis, a rare genetic skin condition. Researchers asked about pain, social life, work, and finances to learn how the disease affects overall well-being. The goal was to gather insights, not to test a treatmen…
Matched conditions: CONGENITAL ICHTHYOSIS
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC